CureVac NV Cash Flow-to-Debt Ratio
CureVac NV cash flow-to-debt ratio. CureVac NV (5CV) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of €29.86 Million could theoretically repay 0% of its total liabilities (€267.39 Million) in one year. Check 5CV cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CureVac NV (2018–2024)
Cash flow-to-debt ratio of CureVac NV from 2018 to 2024. Historical debt coverage capacity for CureVac NV across 7 annual periods. Check CureVac NV cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CureVac NV Cash Flow-to-Debt Ratio by Year (2018–2024)
CureVac NV cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for CureVac NV. For the full cash flow conversion analysis, see cash flow conversion of CureVac NV.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.96x | €101.85 Million | €106.22 Million | ▲ +197.1% |
| 2023 | -0.99x | €-267.89 Million | €271.31 Million | ▼ -12.9% |
| 2022 | -0.87x | €-286.18 Million | €327.22 Million | ▲ +44.0% |
| 2021 | -1.56x | €-733.13 Million | €469.77 Million | ▼ -339.0% |
| 2020 | 0.65x | €522.40 Million | €800.01 Million | ▲ +230.2% |
| 2019 | -0.50x | €-86.96 Million | €173.42 Million | ▲ +36.7% |
| 2018 | -0.79x | €-74.11 Million | €93.58 Million | — |